Pubblicazioni

Articoli scientifici pubblicati su riviste internazionali a nome del Dott. Fabio Artosi.

2024

Prevalence of fungal colonization among patients with psoriasis in difficult-to-treat areas: impact of apremilast on mycotic burden and clinical outcomes

Frontiers in Immunology, 15, 1508489DOI

2024

Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study

Pharmaceuticals, 17(10), 1378DOI

2024

Epidemiological and clinical analysis of exposure-related factors in non-melanoma skin cancer: A retrospective cohort study

Environmental Research, 247, 118117DOI

2024

Efficacy and safety of tildrakizumab in elderly patients: real-world multicenter study (ESTER-study)

Journal of Dermatological TreatmentDOI

2024

Dermanyssus gallinae dermatitis in a young Italian woman

Italian Journal of Dermatology and Venereology, 159(5), 593–595DOI

2024

Challenging case of tinea corporis and faciei in psoriatic patient treated with bimekizumab: The usefulness of mycological screening before biological therapies

Medical Mycology Case Reports, 46, 100683DOI

2024

Apremilast as a Potential Targeted Therapy for Metabolic Syndrome in Patients with Psoriasis: An Observational Analysis

Pharmaceuticals, 17(8), 989DOI

2023

Relationship between collagen disorders and hidradenitis suppurativa regarding two cases of Loeys-Dietz syndrome

European Journal of Pediatric Dermatology, 33(2), 116–119DOI

2023

Preliminary Evidence of Efficacy, Safety, and Treatment Satisfaction with Tirbanibulin 1% Ointment: A Clinical Perspective on Actinic Keratoses

Pharmaceuticals, 16(12), 1686DOI

2023

Mepolizumab induced palmoplantar psoriasis: A case report

World Journal of Clinical Cases, 11(26), 6154–6158DOI